cilostazol has been researched along with Death, Sudden, Cardiac in 4 studies
Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol was discontinued 2 days before replacement because of its antiplatelet effects." | 5.40 | Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes. ( Ayabe, R; Ebata, Y; Fukui, A; Nakagawa, M; Okada, N; Shinohara, T; Takahashi, N; Yufu, K, 2014) |
| "Cilostazol was discontinued 2 days before replacement because of its antiplatelet effects." | 1.40 | Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes. ( Ayabe, R; Ebata, Y; Fukui, A; Nakagawa, M; Okada, N; Shinohara, T; Takahashi, N; Yufu, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shinohara, T | 1 |
| Ebata, Y | 1 |
| Ayabe, R | 1 |
| Fukui, A | 1 |
| Okada, N | 1 |
| Yufu, K | 1 |
| Nakagawa, M | 1 |
| Takahashi, N | 1 |
| Patocskai, B | 1 |
| Barajas-Martinez, H | 1 |
| Hu, D | 1 |
| Gurabi, Z | 1 |
| Koncz, I | 1 |
| Antzelevitch, C | 1 |
| Hong, MK | 1 |
| Mintz, GS | 1 |
| Lee, CW | 1 |
| Kim, YH | 1 |
| Lee, SW | 1 |
| Song, JM | 1 |
| Han, KH | 1 |
| Kang, DH | 1 |
| Song, JK | 1 |
| Kim, JJ | 1 |
| Park, SW | 1 |
| Park, SJ | 1 |
| Saniabadi, AR | 1 |
| Takeich, S | 1 |
| Yukawa, N | 1 |
| Nakajima, Y | 1 |
| Umemura, K | 1 |
| Nakashima, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Revascularization With Paclitaxel-coated Balloon Angioplasty Versus Drug-eluting Stenting in Acute Myocardial Infarction - a Randomized Controlled Trial.[NCT02219802] | 120 participants (Anticipated) | Interventional | 2014-08-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for cilostazol and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes.
Topics: Adult; Anti-Arrhythmia Agents; Bepridil; Cilostazol; Death, Sudden, Cardiac; Dose-Response Relations | 2014 |
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sud | 2016 |
Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
Topics: Aged; Aspirin; Atherectomy, Coronary; Catheterization; Cilostazol; Combined Modality Therapy; Corona | 2004 |
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; A | 1998 |